HI-Bio
Jen Wilson is a seasoned professional in the biopharmaceutical industry with extensive experience in program and portfolio management. Currently serving as Sr. Director at HI-Bio, a Biogen Company, Jen has previously held significant leadership positions, including Executive Director of Program and Portfolio Management at Nurix Therapeutics and Sr. Director of Project and Portfolio Management at Principia Biopharma. Jen also held the role of Director of Project Management at Catalyst Biosciences and Director of Program Management at BeiGene, contributing to various successful projects and initiatives throughout the career in the sector.
This person is not in any teams
This person is not in any offices
HI-Bio
HI-Bio was established on the premise that treatments for immune-mediated illnesses have the potential to provide patients with better outcomes. Many IMDs are caused by immune system cells, such as mast cells, neutrophils, plasma cells, and more, which are dysfunctional. These cells are in charge of crucial processes and functions. With the useof medicines, HI-efforts Bio uses a precision medicine strategy to target, modify or deplete key cellular disease drivers.HI-Bio was established in 2021 in San Francisco, California.